Extensive research reveals the CDC's weekly publication drew unsupported conclusions about mask effectiveness based on ...

FDA approves Shionogi’s Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy, marking a major milestone for Covid-19 prevention treatments. FDA has approved Shionogi’s Xocova (ensitrelvir) ...

An FDA advisory panel is considering updating the 2026-2027 COVID vaccine. The updated vaccine would target the XFG ...

According to the latest update from BNO News, there are 681 Ebola cases and 56 deaths, but the World Health Organization and ...

A Food and Drug Administration advisory panel on Thursday recommended updating this fall’s Covid shots to target the XFG ...

Kids with autumn birthdays are more likely to get the annual flu shot and therefore less likely to catch the virus compared ...

The FDA’s outside vaccine advisers overwhelmingly recommended Thursday that the agency direct manufacturers to base their 2026-2027 formulas on the dominant XFG Covid variant.

According to the Centers for Disease Control and Prevention's COVID ⁠dashboard, new data is currently unavailable due to low ...

The Trump administration has implemented some of the United States’ most stringent travel restrictions for infectious disease ...

While the symptoms of the Ebola virus and COVID-19 are similar these two are entirely different conditions in terms of ...

FDA panel backs fall Covid shot update to target the XFG variant, enabling manufacturers to reformulate vaccines for the upcoming surge season.

Experts skipped the cicada variant BA.3.2 and last year’s LP.8.1 vaccine strain and recommended monovalent XFG option.